Search company, investor...


Founded Year



Series B | Alive

Total Raised


Last Raised

$49.2M | 19 yrs ago

About Nucleonics

Nucleonics is developing a method of RNA interference to silence disease-causing genes. Initially, the company is applying its technology to develop expressed interfering RNA (eiRNA) therapies for the treatment of chronic Hepatitis B and Hepatitis C viral infections.

Headquarters Location

13 Summit Square Center Suite 305

Langhorne, Pennsylvania, 19047,

United States


Missing: Nucleonics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Nucleonics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Nucleonics Patents

Nucleonics has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Transcription factors, Molecular biology, Gene expression, Human proteins, Biotechnology


Application Date


Grant Date



Related Topics

Transcription factors, Molecular biology, Gene expression, Human proteins, Biotechnology



Latest Nucleonics News

Berkeley Nucleonics Corporation to Showcase their Latest RF/Microwave T&M Equipment at AOC 2022

Oct 21, 2022 October 21, 2022  |  Editorial Team Berkeley Nucleonics Corporation , a leading electronic instrumentation manufacturer, will attend the 59th Annual AOC International Symposium and Convention in Washington, DC, on October 25-27, 2022. The experienced San Rafael team will be in attendance throughout the entire event, meeting with attendees to discuss their current projects and applications and how BNC can help. Visitors attending the 59th annual AOC International Symposium and Convention will be able to find the BNC team at Booth 607. Founded in 1963, the California-based company has become one of the global leaders in the manufacture of precision electronic instrumentation for testing and measurement, radiation detection, nuclear research, and RF/microwave. At the symposium, they will showcase their innovative array of cutting-edge signal sources, phase noise testers, and other test and measurement equipment. Speaking ahead of the event, Allan Gonzalez, Vice President at Berkeley Nucleonics Corporation added, “We are really excited to be heading to the 2022 AOC International Symposium and Convention. It is one of the biggest events in our industry and is a fantastic opportunity for our team to meet with both military and government professionals, as well as allow them to learn more about our extensive range of products. Our experienced team is going to be in attendance throughout the three days, and we are really looking forward to meeting as many attendees as possible.” Considered the premier event for electronic warfare, electromagnetic spectrum operations, cyber-electromagnetic activities, and information operations professionals, the annual AOC International Symposium and Convention will welcome over 2,000 industry, military, and government individuals over the three days.

Nucleonics Frequently Asked Questions (FAQ)

  • When was Nucleonics founded?

    Nucleonics was founded in 2001.

  • Where is Nucleonics's headquarters?

    Nucleonics's headquarters is located at 13 Summit Square Center, Langhorne.

  • What is Nucleonics's latest funding round?

    Nucleonics's latest funding round is Series B.

  • How much did Nucleonics raise?

    Nucleonics raised a total of $50.8M.

  • Who are the investors of Nucleonics?

    Investors of Nucleonics include SR One, New Enterprise Associates, Anthem Capital, Burrill & Company, POSCO Capital and 6 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.